Patients with T-cell ALL treated with chemotherapy and an escalating methotrexate regimen had survival outcomes superior to those of patients given high-dose methotrexate.
Patients with T-cell ALL treated with chemotherapy and an escalating methotrexate regimen had survival outcomes superior to those of patients given high-dose methotrexate.
Patients with T-cell ALL treated...